148 related articles for article (PubMed ID: 16490163)
1. Electrophysiological effect of fluoxetine on Xenopus oocytes heterologously expressing human serotonin transporter.
Wang HW; Li CZ; Yang ZF; Zheng YQ; Zhang Y; Liu YM
Acta Pharmacol Sin; 2006 Mar; 27(3):289-93. PubMed ID: 16490163
[TBL] [Abstract][Full Text] [Related]
2. Voltage and ionic regulation of human serotonin transporter in Xenopus oocytes.
Li C; Zhong H; Wang Y; Wang H; Yang Z; Zheng Y; Liu K; Liu Y
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1088-92. PubMed ID: 17042919
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells.
Iceta R; Mesonero JE; Alcalde AI
Life Sci; 2007 Mar; 80(16):1517-24. PubMed ID: 17289086
[TBL] [Abstract][Full Text] [Related]
4. Substrate and Inhibitor-Specific Conformational Changes in the Human Serotonin Transporter Revealed by Voltage-Clamp Fluorometry.
Söderhielm PC; Andersen J; Munro L; Nielsen AT; Kristensen AS
Mol Pharmacol; 2015 Oct; 88(4):676-88. PubMed ID: 26174773
[TBL] [Abstract][Full Text] [Related]
5. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
[TBL] [Abstract][Full Text] [Related]
6. [Establishment of heterologous expression model of hSERT in Xenopus laevis oocytes].
Wang YY; Jin Z; Li CZ; Liu YM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Nov; 21(4):444-8. PubMed ID: 21180171
[TBL] [Abstract][Full Text] [Related]
7. H+ permeation and pH regulation at a mammalian serotonin transporter.
Cao Y; Mager S; Lester HA
J Neurosci; 1997 Apr; 17(7):2257-66. PubMed ID: 9065487
[TBL] [Abstract][Full Text] [Related]
8. Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac).
Ni YG; Miledi R
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):2036-40. PubMed ID: 9050900
[TBL] [Abstract][Full Text] [Related]
9. Stereoselective inhibition of serotonin transporters by antimalarial compounds.
Beckman ML; Pramod AB; Perley D; Henry LK
Neurochem Int; 2014 Jul; 73():98-106. PubMed ID: 24161619
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the human serotonin transporter mediated by long-term action of serotonin in Caco-2 cells.
Iceta R; Aramayona JJ; Mesonero JE; Alcalde AI
Acta Physiol (Oxf); 2008 May; 193(1):57-65. PubMed ID: 18081886
[TBL] [Abstract][Full Text] [Related]
11. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Mitchell SN; Greenslade RG; Cooper J
Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
[TBL] [Abstract][Full Text] [Related]
12. Transporter-mediated release: a superfusion study on human embryonic kidney cells stably expressing the human serotonin transporter.
Scholze P; Zwach J; Kattinger A; Pifl C; Singer EA; Sitte HH
J Pharmacol Exp Ther; 2000 Jun; 293(3):870-8. PubMed ID: 10869387
[TBL] [Abstract][Full Text] [Related]
13. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
Chen F; Larsen MB; Sánchez C; Wiborg O
Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
[TBL] [Abstract][Full Text] [Related]
14. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
[TBL] [Abstract][Full Text] [Related]
15. Molecular and functional characterization of the Gulf toadfish serotonin transporter SLC6A4.
Amador MHB; McDonald MD
J Exp Biol; 2018 Apr; 221(Pt 7):. PubMed ID: 29487159
[TBL] [Abstract][Full Text] [Related]
16. 4-(4-(dimethylamino)phenyl)-1-methylpyridinium (APP+) is a fluorescent substrate for the human serotonin transporter.
Solis E; Zdravkovic I; Tomlinson ID; Noskov SY; Rosenthal SJ; De Felice LJ
J Biol Chem; 2012 Mar; 287(12):8852-63. PubMed ID: 22291010
[TBL] [Abstract][Full Text] [Related]
17. The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
Rasmussen K; Calligaro DO; Czachura JF; Dreshfield-Ahmad LJ; Evans DC; Hemrick-Luecke SK; Kallman MJ; Kendrick WT; Leander JD; Nelson DL; Overshiner CD; Wainscott DB; Wolff MC; Wong DT; Branchek TA; Zgombick JM; Xu YC
J Pharmacol Exp Ther; 2000 Aug; 294(2):688-700. PubMed ID: 10900249
[TBL] [Abstract][Full Text] [Related]
18. Forced swimming test and fluoxetine treatment: in vivo evidence that peripheral 5-HT in rat platelet-rich plasma mirrors cerebral extracellular 5-HT levels, whilst 5-HT in isolated platelets mirrors neuronal 5-HT changes.
Bianchi M; Moser C; Lazzarini C; Vecchiato E; Crespi F
Exp Brain Res; 2002 Mar; 143(2):191-7. PubMed ID: 11880895
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of block by fluoxetine of 5-hydroxytryptamine3 (5-HT3)-mediated currents in NCB-20 neuroblastoma cells.
Choi JS; Choi BH; Ahn HS; Kim MJ; Rhie DJ; Yoon SH; Min DS; Jo YH; Kim MS; Sung KW; Hahn SJ
Biochem Pharmacol; 2003 Dec; 66(11):2125-32. PubMed ID: 14609737
[TBL] [Abstract][Full Text] [Related]
20. N,N-dimethyl-thioamphetamine and methyl-thioamphetamine, two non-neurotoxic substrates of 5-HT transporters, have scant in vitro efficacy for the induction of transporter-mediated 5-HT release and currents.
Gobbi M; Funicello M; Gerstbrein K; Holy M; Moya PR; Sotomayor R; Forray MI; Gysling K; Paluzzi S; Bonanno G; Reyes-Parada M; Sitte HH; Mennini T
J Neurochem; 2008 Jun; 105(5):1770-80. PubMed ID: 18248615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
